
- Volume 0 0
YO-YO PART D PREMIUMS: IS IT Rx BAIT AND SWITCH?
Many Medicare patients who signed onwith the lowest cost Part D prescriptiondrug plans last year are facing steepincreases this year, while others are seeingtheir monthly out-of-pocket premiumcharges shrink for 2007.
These yo-yo premiums—the latest wrinklein the continuing litany of concerns surroundingthe year-old Part D prescriptiondrug benefit—drew nationwide attentionwhen the provider of the least expensivedrug plans, Humana, increased monthly premiumsfor >2 million enrolled seniors by anaverage of 60%, effective January 1, 2007.
Actually, those facing only "average"premium hikes are the lucky ones.Massachusetts Medicare patients enrolledin Humana's low-cost ($7.32 per month)plan have been hit with premium hikes of130% (to $16.90), and seniors in severalMidwestern states received increases of466%. At the same time, however, the costfor Humana's low-cost "standard" Part Dcoverage is going down in 3 states—Georgia, Louisiana, and South Carolina.
Other plans, including those sponsoredby AARP, imposed much smaller premiumincreases for 2007, leading consumeractivists to accuse Humana of "bait-and-switch"Part D pricing practices. For theirpart, however, officials at Humana saidthat the increases were justified, and that,even at the higher rates, its Part D premiumsrank among the lowest of all plans inmost states.
Articles in this issue
about 19 years ago
compounding HOTLINEabout 19 years ago
The Good and the Bad of High Cholesterolabout 19 years ago
Compounding Dental Applicationsabout 19 years ago
An Overview and Update of the Controlled Substances Act of 1970about 19 years ago
ccpa SPEAKS OUT: AMP Definition "Defines" Pharmacists out of Medicaidabout 19 years ago
Are We Really Ready? Preparing for Disastersabout 19 years ago
When the Patient Won't Take the Medicineabout 19 years ago
Community Commitment Earns RESPy Awardabout 19 years ago
Kerr's Center Concentrates on Health and Educationabout 19 years ago
Mandatory Periodic Breaks for Pharmacists UpheldNewsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.


























